Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets (Scientific Reports, 2018)

(untitled) - Alenazi, Y; Singh, K; Davies, G; Eaton, J; Elders, P; Kawamura, A; Bhattacharya, S